相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bioorthogonal Imaging of Aurora Kinase A in Live Cells
Katherine S. Yang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
A Phase I, dose-finding and pharmacokinetic study of olaparib (AZD2281) in Japanese patients with advanced solid tumors*,†
Noboru Yamamoto et al.
CANCER SCIENCE (2012)
Phase II, Open-Label, Randomized, Multicenter Study Comparing the Efficacy and Safety of Olaparib, a Poly (ADP-Ribose) Polymerase Inhibitor, and Pegylated Liposomal Doxorubicin in Patients With BRCA1 or BRCA2 Mutations and Recurrent Ovarian Cancer
Stan B. Kaye et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors
Elisabet Wahlberg et al.
NATURE BIOTECHNOLOGY (2012)
RGB marking with lentiviral vectors for multicolor clonal cell tracking
Kristoffer Weber et al.
NATURE PROTOCOLS (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Imaging Therapeutic PARP Inhibition In Vivo through Bioorthogonally Developed Companion Imaging Agents
Thomas Reiner et al.
NEOPLASIA (2012)
Cancer imaging by optical coherence tomography: preclinical progress and clinical potential
Benjamin J. Vakoc et al.
NATURE REVIEWS CANCER (2012)
Bioorthogonal Probes for Polo-like Kinase 1 Imaging and Quantification
Ghyslain Budin et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
Mechanistic Rationale for Inhibition of Poly(ADP-Ribose) Polymerase in ETS Gene Fusion-Positive Prostate Cancer
J. Chad Brenner et al.
CANCER CELL (2011)
Analysis of Mitosis and Antimitotic Drug Responses in Tumors by In Vivo Microscopy and Single-Cell Pharmacodynamics
James D. Orth et al.
CANCER RESEARCH (2011)
Tumor Growth Inhibition by Olaparib in BRCA2 Germline-Mutated Patient-Derived Ovarian Cancer Tissue Xenografts
Ursula Kortmann et al.
CLINICAL CANCER RESEARCH (2011)
Rapid Phospho-Turnover by Receptor Tyrosine Kinases Impacts Downstream Signaling and Drug Binding
Laura B. Kleiman et al.
MOLECULAR CELL (2011)
Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study
Karen A. Gelmon et al.
LANCET ONCOLOGY (2011)
A Systems Approach for Tumor Pharmacokinetics
Greg Michael Thurber et al.
PLOS ONE (2011)
A High Precision Survey of the Molecular Dynamics of Mammalian Clathrin-Mediated Endocytosis
Marcus J. Taylor et al.
PLOS BIOLOGY (2011)
Sensitivity and Acquired Resistance of BRCA1;p53-Deficient Mouse Mammary Tumors to the Topoisomerase I Inhibitor Topotecan
Serge A. L. Zander et al.
CANCER RESEARCH (2010)
Basal Dynamics of p53 Reveal Transcriptionally Attenuated Pulses in Cycling Cells
Alexander Loewer et al.
CELL (2010)
A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth
Alexander Roesch et al.
CELL (2010)
Use of the Ki67 Promoter to Label Cell Cycle Entry in Living Cells
Alexander C. Zambon
CYTOMETRY PART A (2010)
Optical imaging of tumor hypoxia dynamics
Gregory M. Palmer et al.
JOURNAL OF BIOMEDICAL OPTICS (2010)
I-124-Iodopyridopyrimidinone for PET of Abl Kinase-Expressing Tumors In Vivo
Mikhail Doubrovin et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Structure of the EGF receptor transactivation circuit integrates multiple signals with cell context
Elizabeth J. Joslin et al.
MOLECULAR BIOSYSTEMS (2010)
Tumor Microvasculature and Microenvironment: Novel Insights Through Intravital Imaging in Pre-Clinical Models
Dai Fukumura et al.
MICROCIRCULATION (2010)
The elaboration of a critical framework for understanding cancer: the cancer stem cell hypothesis
Chris Hemmings
PATHOLOGY (2010)
PARP inhibition: PARP1 and beyond
Michele Rouleau et al.
NATURE REVIEWS CANCER (2010)
On the Role of Cell Signaling Models in Cancer Research
Alejandra C. Ventura et al.
CANCER RESEARCH (2009)
Cancer Stem Cells: The Emerging Challenge of Drug Targeting
Roger Besancon et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Non-genetic cell-to-cell variability and the consequences for pharmacology
Mario Niepel et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2009)
Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis
Sabrina L. Spencer et al.
NATURE (2009)
Structural Adaptation and Heterogeneity of Normal and Tumor Microvascular Networks
Axel R. Pries et al.
PLOS COMPUTATIONAL BIOLOGY (2009)
Red/near-infrared boron-dipyrromethene dyes as strongly emitting fluorophores
Ana B. Descalzo et al.
FLUORESCENCE METHODS AND APPLICATIONS: SPECTROSCOPY, IMAGING, AND PROBES (2008)
Visualizing spatiotemporal dynamics of multicellular cell-cycle progression
Asako Sakaue-Sawano et al.
CELL (2008)
4-[3-(4-Cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: A Novel Bioavailable Inhibitor of Poly(ADP-ribose) Polymerase-1
Keith A. Menear et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Intravital imaging of metastatic behavior through a mammary imaging window
Dmitriy Kedrin et al.
NATURE METHODS (2008)
Limited tissue penetration of taxanes: A mechanism for resistance in solid tumors
Alastair H. Kyle et al.
CLINICAL CANCER RESEARCH (2007)
CellProfiler(TM): free, versatile software for automated biological image analysis
Michael R. Lamprecht et al.
BIOTECHNIQUES (2007)
A two-tiered physiologically based model for dually labeled single-chain Fv-Fc antibody fragments
Gregory Z. Ferl et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Novel multiwavelength microscopic scanner for mouse imaging
H Alencar et al.
NEOPLASIA (2005)
Use of gene expression profiling to direct in vivo molecular imaging of lung cancer
J Grimm et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Dynamic assembly and sustained retention of 53BP1 at the sites of DNA damage are controlled by Mdc1/NFBD1
S Bekker-Jensen et al.
JOURNAL OF CELL BIOLOGY (2005)
Tumor penetration of gefitinib (Iressa), an epidermal growth factor receptor tyrosine kinase inhibitor
D McKillop et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Cell adhesion and signalling by cadherins and Ig-CAMs in cancer
U Cavallaro et al.
NATURE REVIEWS CANCER (2004)
Diversity of mechanism-based pharmacodynamic models
DE Mager et al.
DRUG METABOLISM AND DISPOSITION (2003)
分享论文
